Posts Tagged ‘Fondaparinux’
“Is the generic version of Arixtra as safe and effective as brand Arixtra?” Answer: “Yes”.
The FDA evaluated and approved generic fondaparinux made by Dr. Reddy’s Laboratories Ltd. on July 11, 2011 Read the rest of this entry »
Once or twice daily injections of s.c. anticoagulants for prolonged periods of time can be bothersome and unacceptable for the patient. Use of a once weekly exchanged s.c. port, called Insuflon, can make longer-term s.c. anticoagulant therapy easier and more tolerable. Read the rest of this entry »
Occasionally, a patient is treated with long-term low molecular weight heparin (LMWH) (enoxaparin = Lovenox®; Dalteparin = Fragmin®; Tinzaparin = Innohep®) . LMWH may be given because the patient (a) tolerated warfarin poorly (widely fluctuating INRs; significant side-effects, such as marked hair loss or fatigue), (b) had a recurrent thrombotic event which occured with a therapeutic INR, or (c) is pregnant and needs an anticoaglant because of an increased risk for thrombosis. The main side-effect of long-term LMWH is, of course, bleeding.
Whether LMWH cause osteoporosis is not known, Read the rest of this entry »